These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm. Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260 [TBL] [Abstract][Full Text] [Related]
6. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Clark PB; Soo V; Kraas J; Shen P; Levine EA Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choices. Grange F; Maubec E; Barbe C; Kassouma J; Vitry F; Johanet H; Granel-Brocard F; Boitier F; Girod A; Couturaud B; Saez P; Albert S; Le Clainche A; Descamps V; Avril MF Dermatol Surg; 2011 Feb; 37(2):199-206. PubMed ID: 21269352 [TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value. Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594 [TBL] [Abstract][Full Text] [Related]
9. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma]. Avilés-Izquierdo JA; Lázaro-Ochaita P Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 99mTc-MIBI scintigraphy and sentinel node biopsy in the detection of occult lymph node metastases from cutaneous melanoma. Alonso O; Martínez M; Delgado L; Lago G; Juri C; Borges AL; Lopes de Amorim MC; de Boni D; Espasandín J; Priario J Eur J Dermatol; 2003; 13(5):449-54. PubMed ID: 14693488 [TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma. Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients. Vereecken P; Laporte M; Petein M; Steels E; Heenen M J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):66-73. PubMed ID: 15649194 [TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy in breast cancer and melanoma requires adequate self-audit. Spillane A ANZ J Surg; 2004 May; 74(5):308-13. PubMed ID: 15144247 [TBL] [Abstract][Full Text] [Related]
15. [Prognosis after sentinel node biopsy in malignant melanoma]. Lock-Andersen J; Horn J; Sjøstrand H Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370 [TBL] [Abstract][Full Text] [Related]
16. Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care. McLoone JK; Watts KJ; Menzies SW; Barlow-Stewart K; Mann GJ; Kasparian NA Psychooncology; 2013 Sep; 22(9):1994-2000. PubMed ID: 23382138 [TBL] [Abstract][Full Text] [Related]
17. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133 [TBL] [Abstract][Full Text] [Related]
18. Perception of burden experienced during diagnostic tests by melanoma patients with lymph node metastases. Bastiaannet E; Hoekstra-Weebers JE; Francken AB; Jager PL; van der Jagt EJ; Hoekstra HJ Melanoma Res; 2009 Feb; 19(1):36-41. PubMed ID: 19430404 [TBL] [Abstract][Full Text] [Related]